Liraglutide

Details

Files

Generic Name:

Liraglutide

Project Status:

Complete

Therapeutic Area:

Diabetes mellitus, Type 2

Manufacturer:

Novo Nordisk Canada Inc.

Call for patient/clinician input open:

October 12, 2010

Brand Name:

Victoza

Project Line:

Reimbursement Review

Project Number:

SR0217-000

Call for patient/clinician input closed:

January 10, 2011

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Diabetes mellitus, Type 2

Recommendation Type:

Do not list

Final Recommendation:

September 28, 2011

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Plain Language Recommendation View PDF

Last Updated : November 29, 2010